Aloke Finn, MD is an ACTSI-supported investigator and an assistant professor in the Cardiology Division, Department of Medicine, Emory University. His research combines basic and clinical investigation, focusing on translational research in the area of atherosclerotic coronary artery disease, including mechanisms of disease, treatment, and healing after injury. He likes to travel in his spare time, though that is rare because he has two daughters ages 2 and 4.
Finn recently received funding as the PI of a Medtronic clinical trial at Emory University Hospital Midtown using optical frequency domain imaging to study the healing process after stent placement in patients with diabetes. His co-investigators for this trial are Habib Samady, Henry Liberman, Chandan Devireddy, and Anwer Habib.
Lab Land | Possible diabetes drug/stent interaction
July 10, 2013
Clinical and Angiographic Results After Hybrid Coronary Revascularization.
Halkos ME, Walker PF, Vassiliades TA, Douglas JS, Devireddy C, Guyton RA, Finn AV, Rab ST, Puskas JD, Liberman HA. Ann Thorac Surg. 2013 Oct 17.
Pathology of Second-Generation Everolimus-Eluting Stents versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans.
Otsuka F, Vorpahl M, Nakano M, Foerst JR, Newell JB, Sakakura K, Kutys R, Ladich E, Finn AV, Kolodgie FD, Virmani R. Circulation. 2013 Oct 25.
Early clinical and angiographic outcomes after robotic- assisted coronary artery bypass surgery.
Halkos ME, Liberman HA, Devireddy C, Walker P, Finn AV, Jaber W, Guyton RA, Puskas JD. J Thorac Cardiovasc Surg. 2013 Oct 27.
Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.
Navarese EP, Tandjung K, Claessen B, Andreotti F, Kowalewski M, Kandzari DE, Kereiakes DJ, Waksman R, Mauri L, Meredith IT, Finn AV, Kim HS, Kubica J, Suryapranata H, Aprami TM, Di Pasquale G, von Birgelen C, Kedhi E. BMJ. 2013 Nov.